16-1153793-C-T

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 2P and 6B. PM2BP4_ModerateBS2

The NM_021098.3(CACNA1H):​c.56C>T​(p.Pro19Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000459 in 1,088,150 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P19R) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 30)
Exomes 𝑓: 0.0000046 ( 0 hom. )

Consequence

CACNA1H
NM_021098.3 missense

Scores

2
5
11

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.338

Publications

1 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • epilepsy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.23164025).
BS2
High AC in GnomAdExome4 at 5 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_021098.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1H
NM_021098.3
MANE Select
c.56C>Tp.Pro19Leu
missense
Exon 2 of 35NP_066921.2O95180-1
CACNA1H
NM_001005407.2
c.56C>Tp.Pro19Leu
missense
Exon 2 of 34NP_001005407.1O95180-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1H
ENST00000348261.11
TSL:1 MANE Select
c.56C>Tp.Pro19Leu
missense
Exon 2 of 35ENSP00000334198.7O95180-1
CACNA1H
ENST00000569107.6
TSL:1
c.56C>Tp.Pro19Leu
missense
Exon 2 of 34ENSP00000454990.2H3BNT0
CACNA1H
ENST00000711493.1
c.56C>Tp.Pro19Leu
missense
Exon 2 of 34ENSP00000518778.1A0AAA9YHG8

Frequencies

GnomAD3 genomes
Cov.:
30
GnomAD2 exomes
AF:
0.00
AC:
0
AN:
626
AF XY:
0.00
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000459
AC:
5
AN:
1088150
Hom.:
0
Cov.:
32
AF XY:
0.00000193
AC XY:
1
AN XY:
517890
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
22156
American (AMR)
AF:
0.00
AC:
0
AN:
7764
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
13574
East Asian (EAS)
AF:
0.000163
AC:
4
AN:
24596
South Asian (SAS)
AF:
0.00
AC:
0
AN:
27186
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
22512
Middle Eastern (MID)
AF:
0.000351
AC:
1
AN:
2852
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
924372
Other (OTH)
AF:
0.00
AC:
0
AN:
43138
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.545
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
30
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000113

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Uncertain
0.022
T
BayesDel_noAF
Benign
-0.21
CADD
Benign
20
DANN
Uncertain
1.0
DEOGEN2
Benign
0.12
T
Eigen
Benign
-0.79
Eigen_PC
Benign
-0.79
FATHMM_MKL
Benign
0.043
N
LIST_S2
Benign
0.54
T
M_CAP
Pathogenic
0.99
D
MetaRNN
Benign
0.23
T
MetaSVM
Uncertain
0.055
D
MutationAssessor
Benign
1.1
L
PhyloP100
-0.34
PrimateAI
Pathogenic
0.86
D
PROVEAN
Benign
-1.2
N
REVEL
Uncertain
0.29
Sift
Uncertain
0.027
D
Sift4G
Benign
0.072
T
Polyphen
0.0040
B
Vest4
0.17
MutPred
0.29
Loss of glycosylation at P19 (P = 0.0129)
MVP
0.58
ClinPred
0.13
T
GERP RS
1.8
PromoterAI
-0.013
Neutral
Varity_R
0.057
gMVP
0.41
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1196939283; hg19: chr16-1203793; API